Although the benefits of thrombolytic therapy are well established in patients younger than age 75 years with acute ST-elevation myocardial infarction, the value of thrombolytic treatment in ...
To date, only a few preclinical studies have explored this therapy. Nanomedical approaches for local or targeted delivery of thrombolytic drugs have aroused growing interest (58). However, more in ...
Introduction: Thrombolytic and mechanical thrombectomy therapies are the current standard of care for large vessel occlusion (LVO) stroke. Multiple studies emphasized the impact of time metrics on ...
Background: Our system, comprised of 21 Northeast Ohio hospitals includes 3 Stroke Ready, 10 Primary and 1 Comprehensive Stroke Center (CSC). Alteplase was the standardized thrombolytic until 2022.
Chinese clinical scientist Wang Yongjun has been granted the William M Feinberg Award for Excellence in Clinical Stroke at the 2025 International Str ...